🇺🇸 FDA

Company profile · Sponsor

Rapport

Rapport Therapeutics

RAPP · NYSE pharma BOSTON, MA, USA
Pipeline
5
Drugs
0
Patents
1

Quick answer

Rapport (RAPP) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 1 patent to this profile..

Company facts

Ticker RAPP
Exchange NYSE
Company type pharma
Headquarters BOSTON, MA, USA
SEC CIK 0002012593

Pipeline (5)

Search pipeline →

  1. RAP-219

    Rapport

    Focal Seizure

    phase 3 small molecule active

    2 trials

  2. RAP-219

    Rapport

    Bipolar 1 Disorder

    phase 2 small molecule active

    1 trial

  3. RAP-219

    Rapport

    Focal Epilepsy

    phase 2 small molecule active

    1 trial

  4. RAP-219

    Rapport

    Focal Onset Seizures

    phase 2 small molecule completed

    1 trial

  5. A Phase 1, Open-Label Study to Investigate the TARP-ɣ8 Receptor Occupancy of RAP-219 Using a TARP-γ8 PET Tracer in Healthy Adult Participants

    Rapport

    Epilepsy

    phase 1 other active

    1 trial

Patents (1)

Search patents →

  1. US 12304908

    Azabenzimidazoles and their use as AMPA receptor modulators

    Expires Mon May 15 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is Rapport?

Rapport (RAPP) is a pharma company. headquartered in BOSTON, MA, USA. listed on NYSE. NovaPharmaNews links 5 pipeline programs, 0 drugs, and 1 patent to this profile..

What pipeline programs does Rapport sponsor?

We track 5 ClinicalTrials.gov-linked programs for Rapport, including RAP-219 and 4 more. Open each program for phase, modality, NCT IDs, and indication details.

Where does Rapport company data come from?

Profiles combine SEC EDGAR (CIK/ticker), ClinicalTrials.gov sponsor links, FDA drug records, and USPTO patent metadata. See our data sources page. This profile is for professional reference, not investment advice.